News & Updates
Showing Cardiology articles
Showing
Show Multimedia Only

Are SGLT2 inhibitors cardioprotective in wild-type ATTR-CM patients?
05 Nov 2024
byAudrey Abella
The use of sodium glucose cotransporter-2 (SGLT2) inhibitors nearly halves the risk of all-cause mortality at 3 years in patients with wild-type transthyretin amyloid cardiomyopathy (ATTR-CM) and type 2 diabetes (T2D), findings from an observational study suggest.
05 Nov 2024

Sacubitril/valsartan maintains efficacy, safety in HF patients with hypotension
31 Oct 2024
Both symptomatic and asymptomatic hypotension are associated with worse outcomes during treatment with either enalapril or sacubitril/valsartan, but the benefits derived from the combination therapy are maintained or even improved in heart failure (HF) patients with hypotension, a study has shown.
31 Oct 2024






